Pulse Biosciences, Inc (PLSE) Total Assets by Year
Pulse Biosciences, Inc closed fiscal year 2025 with $94.5M in total assets, $13.9M in total liabilities and $80.7M in shareholder equity. This represents a decrease of 28.6% from the prior fiscal year. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Pulse Biosciences, Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
PLSE Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $94.5M-28.6% | $132.5M+123.9% | $59.2M-24.0% | $77.9M+31.7% | $59.2M+43.3% | $41.3M-1.5% | $41.9M-40.7% | $70.6M+41.8% | $49.8M+89.3% | $26.3M+83.7% | $14.3M |
| Total Liabilities | $13.9M-21.1% | $17.6M+19.0% | $14.8M-81.5% | $80.1M+441.6% | $14.8M-19.6% | $18.4M+64.6% | $11.2M+159.6% | $4.3M+12.5% | $3.8M+276.6% | $1.0M+53.9% | $660K |
| Total Equity | $80.7M-29.8% | $114.9M+158.9% | $44.4M+2073.3% | -$2.2M-105.1% | $44.4M+93.8% | $22.9M-25.5% | $30.7M-53.7% | $66.3M+44.2% | $46.0M+81.8% | $25.3M+85.1% | $13.7M |
PLSE Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $115.6M-3.9% | $81.6M-38.8% | $94.5M-28.6% | $108.8M+16.9% | $120.3M+197.4% | $133.4M+171.3% | $132.5M+123.9% | $93.0M+41.1% | $40.4M-45.9% | $49.2M-30.0% | $59.2M-24.0% | $65.9M-24.7% |
| Total Liabilities | $16.1M+1.9% | $15.3M+2.6% | $13.9M-21.1% | $16.1M+15.5% | $15.8M+17.1% | $14.9M+16.0% | $17.6M+19.0% | $13.9M+0.8% | $13.5M-5.6% | $12.9M-84.1% | $14.8M-81.5% | $13.8M-83.0% |
| Total Equity | $99.5M-4.8% | $66.3M-44.0% | $80.7M-29.8% | $92.7M+17.1% | $104.5M+287.4% | $118.5M+226.4% | $114.9M+158.9% | $79.1M+51.8% | $27.0M-55.4% | $36.3M+440.2% | $44.4M+2073.3% | $52.1M+742.5% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Pulse Biosciences, Inc financials
Frequently Asked Questions
What was Pulse Biosciences, Inc's total assets in fiscal year 2025?
Pulse Biosciences, Inc closed fiscal year 2025 with $94.5M in total assets, $13.9M in total liabilities and $80.7M in shareholder equity.
How fast is Pulse Biosciences, Inc's total assets growing?
Pulse Biosciences, Inc (PLSE) total assets fell by 28.6% year over year, from $132.5M to $94.5M in fiscal year 2025.
How has Pulse Biosciences, Inc's total assets changed over the years?
Across the 11 fiscal years this page covers, Pulse Biosciences, Inc (PLSE) total assets went from $14.3M in fiscal year 2015 to $94.5M in fiscal year 2025.
What was Pulse Biosciences, Inc's total assets in the most recent quarter?
Pulse Biosciences, Inc (PLSE) reported $115.6M in total assets in Q2 2026. This represents a decrease of 3.9% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Pulse Biosciences, Inc (PLSE) reported on that line in every period on record.